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Background: Ventilatory muscle endurance training (VMET) involves increasing minute ventila-
tion ( _VE) against a low flow resistance at rest to simulate the hyperpnea of exercise. Ideally,
VMET must maintain normocapnia over a wide range of _VE. This can be achieved by providing
a constant fresh gas flow to a sequential rebreathing circuit. The challenge to make VMET
suitable for home use is to provide a source of constant fresh gas flow to the circuit without
resorting to compressed gas.
Methods: Our VMET circuit was based on a commercial sequential gas delivery breathing circuit
(PulmanexHi-Ox, ViasysHealthcare, Yorba Linda, CAUSA). Airflowwas provided either by a small
battery-driven aquarium air pump or by the entrainment of air down a pressure gradient created
by the recoil of a hanging bellows thatwas charged during each inhalation. In each case, fresh gas
flowwas adjusted to be just less than resting _VE. Eight subjects then breathed from the circuit for
three 10 min periods consisting of relaxed breathing, breathing at 20 and then at 40 L/min. We
monitored _VE, end-tidal PCO2 (PETCO2) and hemoglobin O2 saturation (SpO2).
Results: During hyperpnea at 20 and 40 L/min, PETCO2 did not differ significantly from resting
levels with eithermethod of supplying fresh gas. SpO2 remained greater than 96% during all tests.cle endurance training; V_E, minute ventilation (L/min); V_A, alveolar ventilation (L/min); PCO2, partial
-tidal partial pressure of CO2 (mmHg); PETO2, end-tidal partial pressure of O2 (mmHg); FGF, fresh gas
n saturation measured via pulse oximetry.
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Ventilatory muscle endurance training 1823Table 1 Anthropometric and ve
Subject # Age (y) Sex
1 22 F
2 24 F
3 34 M
4 23 M
5 25 M
6 30 M
7 36 F
8 59 M
Mean 31.6
SD 12.2Conclusion: Isocapnic VMET can be reliably accomplished with a simple self-regulating, sequen-
tial rebreathing circuit without the use of compressed gas.
ª 2009 Elsevier Ltd. All rights reserved.Introduction
For endurance exercise training, breathing does for chest
muscles what running does for leg muscles.1 By analogy
then, ventilatory muscle endurance training (VMET) requires
periods of prolonged, sustained increases in minute venti-
lation ( _VE). This differs from training by inhaling against
a resistance, which is analogous to weight training. Indeed,
VMET improves both ventilatory and exercise endurance in
healthy runners,2 swimmers,3 cyclists,4 sedentary volun-
teers,5,6 and wheelchair-bound athletes.7,8 It can also
increase endurance in the elderly,9 individuals with
restrictive lung disease,10 cystic fibrosis,11 myasthenia
gravis,12 and patients recovering from spinal cord injury.13 In
patients with chronic obstructive pulmonary disease
(COPD), VMET improves exercise tolerance as well as the
perception of dyspnea; it even improves quality of life.14e16
With exercise, _VE is matched to O2 consumption and CO2
production so that O2 requirements are met, and end-tidal
partial pressure of CO2 (PETCO2) changes little from that at
rest. VMET ideally exercises only respiratory muscles,
potentially resulting in a low steady state arterial partial
pressure of CO2 (PaCO2). Breathing circuits used for VMET
must therefore reduce the efficiency with which ventilation
eliminates CO2. This is commonly done by replacing some
fixed portion of the inhaled air with previously exhaled gas
(i.e., partial rebreathing), leaving only the atmospheric air
portion of inspired gas (i.e., fresh gas) to contribute to CO2
elimination.17 To maintain isocapnia, however, the flow of
this fresh gas (FGF) e not that of rebreathed gas e must
remain constant despite increases in _VE.
18 Thus, with
devices that use a constant volume of rebreathed gas to
reduce CO2 elimination, one must either accept some
variations in PETCO2 as _VE varies
15 or, attempt to restrain
tidal volume and breathing frequency14 to fixed levels.
The ideal VMET system for home use would have two
important properties. The first is that it should maintain
normocapnia over a wide range of _VE. Isocapnia can be
maintained independently of _VE if the FGF remains constantntilation data for all subjects.
Ht (cm) Wt (kg)
150 42.3
173 68.2
168 63.6
170 59.1
173 59.1
185 86.4
179 84.1
183 77.7
67.9 67.6
4.3 14.8and the balance of _VE is made up with previously exhaled
gas (partial rebreathing).17,19 Banzett et al.19 have pointed
out that the sequential gas delivery circuit is one such self-
regulating system. However, its source of fresh gas tradi-
tionally comes from a cylinder of compressed gas, which is
impractical to install outside of large institutions. This
leads to the second desirable property of a home system: it
should operate without compressed gas.
Our aim was to test the concept of a ‘‘home-use’’ VMET
circuit based on sequential gas delivery for maintaining
normocapnia. To provide constant FGF without compressed
gas, we tested two systems: a commercial battery-driven
aquarium aeration pump and a custom, self-charging
bellows that needs no external power. We did so by
assessing their ability to maintain normocapnia and
peripheral oxygen saturation (SpO2) over a wide range of _VE.
Methods
After approval from our institutional ethics review board,
eight healthy, non-smoking subjects gave written informed
consent to participate in this study. Anthropometric data
are shown in Table 1.
Breathing circuit
The breathing circuit consisted of a commercially available
sequential gas delivery breathing manifold (Pulmanex Hi-
Ox, Viasys Healthcare, Yorba Linda, CA USA) modified by
adding a gas reservoir to the expiratory limb17 (Fig. 1).
When _VE exceeds the FGF, previously exhaled gas is inhaled
from the expiratory reservoir via the bypass limb.
FGF sources
For the first source of fresh gas, we used a battery-driven
aquarium air pump (2.4 W, A.1F21N2.C12VDC, Hargraves,
Mooresville, NC USA) (Fig. 1b). A mass gas flow meter
(AWM700, Honeywell, Morristown, NJ USA) was used to_VA Control
(L/min)
PETCO2 control
(mmHg)
SpO2 control (%)
3.7 39.6 97.4
6.9 40.6 97.7
5.7 40.4 97.6
6.8 35.4 97.9
4.3 41.3 97.7
6.3 41.7 97.1
6.7 39.2 97.5
4.6 36.7 97.4
5.6 39.4 97.5
1.3 2.2 0.2
Figure 1 Schematics of VMET circuits. a: Generic sequential rebreathing circuit with fresh gas supplied by pressurized gas source.
b: gas flow is supplied by a battery operated pump; c: schematic of a bellows system charged during inspiration to provide
a pressure gradient for entrainment of air during exhalation and thereby provide a near constant flow of air (FGF) to the circuit
throughout the respiratory cycle.
Figure 2 Relation between air flow and length of the resis-
tance tubing. The pressure gradient was generated by
a subject breathing on the circuit with the weighted bellows
(see Methods).
1824 D.Y. Balaban et al.calibrate the pump dial settings between 2 and 10 L/min
and monitor gas flow.
For the second source of FGF, we assembled a system
designed to provide near constant FGF caused by the pres-
sure gradient resulting from the recoil of a weighted bellows
that collapsed with each inhalation (Fig. 1c). The weight on
the bellows plate was calibrated such that the pressure
differential across the weight was less than the 2.5 cmH2O
opening pressure of the valve on the cross-over limb of the
breathing manifold. To control the FGF from the bellows to
the inlet of the breathing manifold, we varied the length of
the 0.32 mm i.d. inflow resistance tubing. An electronic
flowmeter (4040E, TSI, Shoreview, MN USA) was used to
determine the flow-length relation of the resistance tubing.
A subject breathed at 20 L/min through the circuit to
generate the pressure gradient for calibrating the tubing
lengths. As the pressure gradient across the tubing is limited
by the opening pressure of the cross-over valve, it varies
within a small range during a breath at any _VE (Fig. 2). The
resulting flow through the resistance tubing is therefore
primarily a function of its length (L). L (in cm) was chosen
according to the required FGF from the empirically derived
relationship LZ 319.26e(0.5022 *FGF) (Fig. 2).
_VE was monitored by a pneumotachograph (Vmax,
Viasys HealthCare, Yorba Linda, CA USA) on the inspiratory
limb of the breathing circuit, and displayed breath-
by-breath on a screen visible to the subject. Tidal gas was
sampled from inside the face mask and analyzed for
PETCO2 and PETO2 (Vmax, Viasys HealthCare, Yorba Linda,
CA USA). Blood oxygen saturation (SpO2) was monitored
continuously by pulse oximetry (AS/3 Datex-Ohmeda,
Stockholm Sweden).Protocol
Subjects were seated comfortably in a laboratory. They held
the mask connected to the breathing circuit tightly to their
faces to ensure an air-tight seal. The expiratory reservoir
was only attached to the VMET circuit after the fresh gas
source was confirmed to be operational; at all other times,
the inspiratory limb of the circuit was open to room air.
First, the air pump (and the expiratory reservoir) was
attached to the breathing circuit. The air pump was initially
set to provide a FGF of air well in excess of _VE (as judged
from sustained distension of the fresh gas reservoir). After
10 min, the pump flow was adjusted to just less than _VE as
indicated by collapse of the inspiratory reservoir and an
Table 2 PETCO2 and SpO2 at _VE of 20 and 40 L/min with
two sources of air flow (* indicates difference from Control
at p< 0.05 level).
PUMP Control 20 L/min 40 L/min
PETCO2 (mmHg) 39.4 2.2 39.3 1.2 40.2 3.0
SpO2 (%) 97.5 0.2 97.5 0.2 97.3 0.4
_VE (L/min) 7.8 1.0 20.1 1.3 38.7 2.5
FGF (L/min) 5.6 1.3 5.6 1.3 5.3 1.3
Bellows Control 20 L/min 40 L/min
PETCO2 (mmHg) 39.4 2.2 41.4 2.0 39.1 2.3
SpO2 (%) 97.5 0.2 97.2 0.4* 97.5 0.3
_VE (L/min) 7.8 1.0 21.4 2.0 39.5 1.6
FGF (L/min) 5.6 1.3 4.7 1.2* 5.5 1.5
Ventilatory muscle endurance training 1825increase in PCO2 on the capnograph tracing during the
latter part of inspiration. Subjects breathed at rest for at
least an additional 2 min to ensure that PETCO2 remained
stable between 39 and 41 mmHg. The resulting airflow
(i.e., FGF) was assumed to be equivalent to alveolar
ventilation ( _VA).
17 Subjects were then asked to increase _VE
to approximately 20 L/min for 10 min. _VE was controlled by
using visual feedback from the values of _VE displayed on the
screen of the metabolic cart.
The pump assembly was then detached and the self-
inflating bellows was connected to the inspiratory limb of
the breathing circuit (Fig. 1c). A length of resistance tubing
was chosen to provide the same flow as that produced by
the pump. Subjects were asked once again to increase _VE to
approximately 20 L/min. This protocol was subsequently
repeated at a _VE of 40 L/min using both the pump assembly
and the self-inflating bellows. Subjects rested for at least
5 min between tests.
All analogdataweredigitizedand recordedoncustomized
data acquisition software (LabView 7.1, National Instru-
ments, Austin, TX USA). Data during the last 3 min of each
protocol were analyzed for average PETCO2, SpO2 and _VE.
We evaluated the precision of FGF delivery by the two
methods by comparing observed flow to target flow under
each _VE condition. We evaluated the ability of the circuit to
maintain arterial gas concentrations by comparing PETCO2
and SpO2 during each _VE condition to baseline levels.
Comparisons were done using a two factor repeated
measures ANOVA, with an alpha level of 0.05. All statistics
were performed using SigmaStat (Aspire Software Interna-
tional, Ashburn, VA USA).
Results
All subjects were able to complete the protocol without
any discomfort or symptoms indicative of hypocapnia,
hypercapnia, or hypoxia. At no time did PETCO2 fall below
35 mmHg or exceed 45 mmHg, or SpO2 fall below 96%.
The _VE and PETCO2 of a representative subject are shown
in Fig. 3. PETCO2 did not differ significantly from control
levels when either the pump (FZ 0.41, pZ 0.748) or the
tube assembly (FZ 1.99, pZ 0.15) was used. SpO2
remained greater than 96% during all tests (Table 2).
Increases in _VE tended to increase the flow of entrainedFigure 3 Breath-by-breath measurements of PETCO2 and _VE
from a representative subject. The circuit maintained normo-
capnia despite an approximate 6-fold increase in _VE.fresh gas (p< 0.01) with both methods, but not sufficiently
to affect PETCO2.
Discussion
Our VMET circuits maintained PETCO2 at resting levels (i.e.,
normocapnia) for all subjects even during a more than 6-fold
increase in _VE above resting levels. This was achieved by
providing a constant FGF to a sequential rebreathing circuit,
enabling it to maintain normocapnia independent of _VE. The
aim of making the system independent of compressed gas is
to improve its portability, reduce its cost, and thus increase
its practicality for use outside the clinical setting.
In 1976, Leith and Bradley first demonstrated that sus-
tained normocapnic hyperpnea is more effective for respi-
ratorymuscle endurance training (as indicatedby ventilatory
endurance during maximum voluntary ventilation) than
resistance training.1 Since then,multiple studies have shown
that VMET increases ventilatory capacity, exercise toler-
ance, and reduces breathlessness during exercise.2,4,6 In
patients with cystic fibrosis, VMET for 25 minutes a day, 5
days per week for 4 weeks improved ventilatory muscle
endurance as much as intense physical activity for 1.5 h per
day.11 Hyperpnea training also improves inspiratory muscle
strength, peakoxygenconsumption ( _VO2max),maximalwork
rate, and even quality of life in subjects with restrictive lung
disease.10 In patients with COPD, VMET improves maximal
sustained ventilatory capacity, _VO2max, and maximal _VE
during exercise.14e16 Similar results have been obtained in
patients with neuromuscular disorders due to spinal cord
injury 7,8,13 and myasthenia gravis.12
To be effective, VMET training generally requires about
20 min per day, 5 days a week for at least a month. Such
intensive training precludes visits to a clinic and can only be
managed if it can be performed at home. The available
portable systems recommended for home use fix the extent
of rebreathing rather than the rate of entrainmentof air ( _VA),
thus allowing PETCO2 to vary with _VE. Such systems require
constant interventions to maintain normocapnia1,2 but
PETCO2maynevertheless varywidely (from33
15 to>53 mmHg
5) with _VE. The advantage of a system based on sequential
rebreathing is that, as long as the FGF entering the circuit is
constant, _VA, and hence PETCO2, remain constant over a wide
range of _VE.
20 For portability and out-of-clinic use, a method
ofmaintaining a constant FGFwithout the need for a cylinder
1826 D.Y. Balaban et al.of compressed gas is necessary. One obvious method is to
provide ambient air from a simple battery-powered elec-
trical pump. Our 2.4 W aquarium pump can run for 8 h when
powered by a single 12 volt lead acid battery.
How tomaintain a constant FGFwithout external power is
lessobvious.Thepressureacrossapartially expandedbellows
is determined by the weight of the bellows plate and its
surface area. During inspiration, the pressure should there-
fore remain constant (ignoringmomentumof theweight).We
selected a weight for the plate that would require a pressure
of approximately1.5 cmH2O to lift it. The opening pressure
of the cross-over valve is approximately 2.5 cmH2O. Thus,
during inspiration, as long as the pressure in the breathing
circuit remains between 1.5 and 2.5 cmH2O, the bellows
will collapse (i.e., the plate will rise). Once the bellows
collapses, continued inspiratory effort reduces the pressure
in the bellows to less than the opening pressure of the cross-
over valve. Opening of the cross-over valve allows previously
exhaled gas to be inhaled from the expiratory reservoir.
Throughout this phase of inhalation, the pressure inside the
bellows remains constant at the opening pressure of the
cross-over valve, i.e., 2.5 cmH2O.
We used this same system to generate the pressure
gradient used to calibrate the lengths of resistance tubing
that determine the FGF into the bellows. Because the
fluctuation of the pressure gradient across the tubing
remained within approximately 1 cmH2O throughout the
respiratory cycle (i.e., between 1.5 and 2.5 cmH2O), and
the resistance to flow in the tubing was constant, the
entrained flow of air (i.e., FGF) was essentially constant.
And, as mentioned above, as long as the FGF is constant, _VA
(and therefore PETCO2) remains constant. Table 2 indicates
that the small variations in the FGF entrained by the
bellows assembly were too small to affect the PETCO2.
One limitation of our approach is that the FGF must
initially be set equal to _VA. One can identify when FGF equals
_VE because the volume of the inspiratory reservoir at the end
of inspiration remains constant. _VA is then obtained by
making a small, arbitrary reduction in FGF below _VE. ‘‘Small’’
may be imprecise but, in practice, there is considerable
leeway in the FGF reduction. In our study, to obtain a FGF
‘‘equal to _VA’’, we reduced the FGF until PETCO2 rose above
resting values during the latter part of inspiration, indicating
rebreathing. As previously argued,17,18 this rebreathed gas
flows into the anatomical deadspace and has no effect on
PETCO2. Assuming a 70 Kg male with tidal volume of 0.5 L and
anatomical deadspace of 0.014 L, FGF can be reduced by
nearly one third without resulting in an increase in PETCO2
(see discussion in Somogyi et al.17). Once the FGF is set, the
stability of the PETCO2 depends on the constancy of CO2
production.17 Although _VA is constant, CO2 production may
increase with even small movements, such as changing body
position or tensing muscles, or with increased work of
breathing21 that accompanies the increased _VE. Conversely,
CO2 production may decrease if the subject relaxes tensed
muscles. In our study, these uncontrolled variables did not
seem to affect PETCO2.
Conclusion
A sequential rebreathing circuit is self-regulating with
respect to PETCO2, providing the basis for a simple VMETsystem that maintains isocapnia over a wide range of _VE.
The additional requirement of a constant fresh gas flow can
be met by using either of the two compact, inexpensive
systems which we propose: a simple battery-driven
aquarium pump, and a self-charging bellows system. Both
eliminate the need for a cylinder of compressed gas. In our
study each system maintained normocapnia and normal
SpO2 during VMET despite a 6-fold increase in _VE.Conflict of interest statement
Patent applications for the method and apparatus of
maintaining constant PCO2 have been filed according to the
intellectual property guidelines of the University Health
Network in Toronto, Canada. DP, JF, JD, MS and SI may
benefit financially should this technology be successfully
commercialized.
DYB, AM, JSH, RR, GDW have no conflicts of interest to
disclose.References
1. Leith DE, Bradley M. Ventilatory muscle strength and endur-
ance training. J Appl Physiol 1976;41:508e16.
2. Leddy JJ, Limprasertkul A, Patel S, Modlich F, Buyea C,
Pendergast DR, et al. Isocapnic hyperpnea training improves
performance in competitive male runners. Eur J Appl Physiol
2007;99:665e76.
3. Lindholm P, Wylegala J, Pendergast DR, Lundgren CE. Resistive
respiratory muscle training improves and maintains endurance
swimming performance in divers. Undersea Hyperb Med 2007;
34:169e80.
4. Stuessi C, Spengler CM, Knopfli-Lenzin C, Markov G,
Boutellier U. Respiratory muscle endurance training in humans
increases cycling endurance without affecting blood gas
concentrations. Eur J Appl Physiol 2001;84:582e6.
5. Koppers RJ, Vos PJ, Folgering HT. Tube breathing as a new
potential method to perform respiratory muscle training: safety
in healthy volunteers. Respir Med 2006;100:714e20.
6. Boutellier U. Respiratory muscle fitness and exercise endurance
in healthy humans. Med Sci Sports Exerc 1998;30:1169e72.
7. Mueller G, Perret C, Spengler CM. Optimal intensity for respi-
ratory muscle endurance training in patients with spinal cord
injury. J Rehabil Med 2006;38:381e6.
8. Mueller G, Perret C, Hopman MT. Effects of respiratory muscle
endurance training on wheelchair racing performance in
athletes with paraplegia: a pilot study. Clin J Sport Med 2008;
18:85e8.
9. Belman MJ, Gaesser GA. Ventilatory muscle training in the
elderly. J Appl Physiol 1988;64:899e905.
10. Budweiser S, Moertl M, Jorres RA, Windisch W, Heinemann F,
Pfeifer M. Respiratory muscle training in restrictive thoracic
disease: a randomized controlled trial. Arch Phys Med Rehabil
2006;87:1559e65.
11. Keens TG, Krastins IR, Wannamaker EM, Levison H, Crozier DN,
Bryan AC. Ventilatory muscle endurance training in normal
subjects and patients with cystic fibrosis. Am Rev Respir Dis
1977;116:853e60.
12. Rassler B, Hallebach G, Kalischewski P, Baumann I, Schauer J,
Spengler CM. The effect of respiratory muscle endurance
training in patients with myasthenia gravis. Neuromuscul Dis-
ord 2007;17:385e91.
13. Van Houtte S, Vanlandewijck Y, Kiekens C, Spengler CM,
Gosselink R. Patients with acute spinal cord injury benefit from
Ventilatory muscle endurance training 1827normocapnic hyperpnoea training. J Rehabil Med 2008;40:
119e25.
14. Ries AL, Moser KM. Comparison of isocapnic hyperventilation
and walking exercise training at home in pulmonary rehabili-
tation. Chest 1986;90:285e9.
15. Scherer TA, Spengler CM, Owassapian D, Imhof E,
Boutellier U. Respiratory muscle endurance training in chronic
obstructive pulmonary disease: impact on exercise capacity,
dyspnea, and quality of life. Am J Respir Crit Care Med 2000;
162:1709e14.
16. Koppers RJ, Vos PJ, Boot CR, Folgering HT. Exercise perfor-
mance improves in patients with COPD due to respiratory
muscle endurance training. Chest 2006;129:886e92.
17. Somogyi RB, Vesely AE, Preiss D, Prisman E, Volgyesi G,
Azami T, et al. Precise control of end-tidal carbon dioxidelevels using sequential rebreathing circuits. Anaesth Intensive
Care 2005;33:726e32.
18. Sommer LZ, Silverman J, Dickstein J, Fink A, Robicsek A,
Sommer D, et al. Simple passive system to keep PCO2 constant
despite increased minute ventilation. Am J Respir Crit Care
Med 1996;153:A786.
19. Banzett RB, Garcia RT, Moosavi SH. Simple contrivance
‘‘clamps’’ end-tidal PCO2 and PO2 despite rapid changes in
ventilation. J Appl Physiol 2000;88:1597e600.
20. Slessarev M, Han J, Mardimae A, Prisman E, Preiss D,
Volgyesi G, et al. Prospective targeting and control of end-tidal
CO2 and O2 concentrations. J Physiol 2007;581:1207e19.
21. Bradley ME, Leith DE. Ventilatory muscle training and the
oxygen cost of sustained hyperpnea. J Appl Physiol 1978;45:
885e92.
